The Living With a Long-Term Condition Study

NCT ID: NCT06072287

Last Updated: 2023-10-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-28

Study Completion Date

2024-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Psychological distress (anxiety and depression) is common in and experienced differently by people living with long-term health conditions (LTCs). Being able to measure whether psychological distress is related to living with a LTC would allow researchers and clinicians to provide interventions specifically tailored to the challenges of living with a LTC and therefore provide the most appropriate support for these patients. Such a measure would also be useful in research to identify the presence of illness-related distress in different patient groups. This project will therefore create a new measure of illness-related distress that has applications for both research and clinical practice. This will involve the psychometric validation of the new illness-related distress measure to test how valid and reliable the measure is.

The aim of the project is to provide initial validation of the Illness Related Distress Scale in a community sample, recruited through online platforms. The objective of the study is to gather initial validity and reliability data for the scale.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: see brief summary

Project information:

This study will be conducted online with participants from the UK. A series of standardised questionnaires will be used alongside the new questionnaire.

Participants will be those who self-select to complete our survey by responding to advertisements. The invitation will include a link to the Qualtrics survey which includes the Participant Information Sheet, Eligibility Screening, Consent Form and Baseline Questionnaire.

After completing eligibility screening and consent, participants will complete the baseline questionnaire which will include brief demographics (highest education level, long-term condition diagnoses, ethnicity age and gender), the new measure we are testing (the Illness Related Distress Scale), as well as the Patient Health Questionnaire (PHQ-8), Generalised Anxiety Disorder Scale (GAD-7), the Work and Social Adjustment Scale (WSAS). The baseline questionnaire will only include the Inflammatory Bowel Disease Distress Scale (IBD-DS) and Diabetes Distress Scale (DDS) if participants indicate that they have a diagnosis of the relevant condition.

At 1 week follow-up, participants will be sent a Qualtrics link to complete our 1-week follow-up questionnaire which will include the new Illness-Related Distress Scale only.

Participants:

We are aiming to recruit 600-700 participants for the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Atrial Fibrillation Cancer Cerebrovascular Disorders Stroke CKD Copd Fibromyalgia Pain Heart Diseases Heart Disease Chronic Dementia Diabetes Epilepsy Heart Failure High Blood Pressure Hypertension Hiv AIDS IBD IBS Liver Diseases Long COVID Lupus Erythematosus Multiple Sclerosis Obesity Osteoarthritis Arthritis Rheumatoid Arthritis Osteoporosis Parkinson Disease Sickle Cell Disease Hepatitis Endometriosis PCOS Neurological Disorder POTS - Postural Orthostatic Tachycardia Syndrome MND (Motor Neurone DIsease) Cystic Fibrosis Migraine Spondylitis Celiac Disease Hidradenitis Suppurativa Eczema ME/CFS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants

Participants will answer two short questionnaires, 1 week apart.

Living with LTC Questionnaire

Intervention Type DIAGNOSTIC_TEST

A questionnaire that will ask about demographic information, mental wellbeing and distress related to chronic illness.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Living with LTC Questionnaire

A questionnaire that will ask about demographic information, mental wellbeing and distress related to chronic illness.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over the age of 18
* Self-reported diagnosis of a Long-Term Condition
* UK resident
* Possession of an email address to enable all study procedures
* Sufficient command of written and spoken English to understand study procedures

Exclusion Criteria

* Under the age of 18
* Not living in the UK
* No self-reported diagnosis of an LTC
* Inability to complete questionnaires in English
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King's College London

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rona Moss-Morris, PhD

Role: PRINCIPAL_INVESTIGATOR

King's College London

Annie Jones, PhD

Role: STUDY_DIRECTOR

King's College London

Emma Jenkinson, MSc

Role: STUDY_DIRECTOR

King's College London

Natasha Seaton, MSc

Role: STUDY_DIRECTOR

King's College London

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

King's College London

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Natasha Seaton, MSc

Role: CONTACT

0207 188 1189

Natasha Seaton, MSc

Role: CONTACT

0207 188 1189

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Natasha Seaton, MSc

Role: primary

0207 188 1189

Role: backup

Related Links

Access external resources that provide additional context or updates about the study.

https://linktr.ee/ltc_study

Study information and sign up

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HR/DP-22/23-36320

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EVOLVING AZIMUTH IN MUSA CONTEXT
NCT07022067 RECRUITING NA
Sleep Health in Pregnant Women in ENRICH
NCT07216287 NOT_YET_RECRUITING